Cassaday & Co Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Cassaday & Co Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02M	Hold	5,383	–	–	0.02%	150
2026 Q1	$909K	Sell	5,383 -153	-3%	-$26.2K	0.02%	148
2025 Q4	$934K	Buy	5,536 +30	+0.5%	+$4.87K	0.02%	144
2025 Q3	$795K	Hold	5,506	–	–	0.02%	161
2025 Q2	$697K	Hold	5,506	–	–	0.02%	173
2025 Q1	$704K	Sell	5,506 -5,650	-51%	-$766K	0.02%	159
2024 Q4	$1.47M	Hold	11,156	–	–	0.04%	87
2024 Q3	$1.62M	Sell	11,156 -48	-0.4%	-$6.95K	0.05%	83
2024 Q2	$1.54M	Sell	11,204 -13	-0.1%	-$1.74K	0.05%	80
2024 Q1	$1.54M	Buy	11,217 +61	+0.5%	+$8.33K	0.05%	79
2023 Q4	$1.52M	Buy	+11,156	New	+$1.36M	0.05%	74

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Cassaday & Co Wealth Management's IBB Position: Q2 2026 in Review

Cassaday & Co Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 5,383 shares worth $1.02M. The position accounts for 0.02% of the portfolio, ranked #150.

Cassaday & Co Wealth Management first reported a position in IBB in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.62M in Q3 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Cassaday & Co Wealth Management held 5,383 shares of iShares Biotechnology ETF worth $1.02M as of Q2 2026.
Cassaday & Co Wealth Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up 0.02% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #150 holding.
Cassaday & Co Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 11 quarters since.
Cassaday & Co Wealth Management's iShares Biotechnology ETF position peaked at $1.62M in Q3 2024.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.